跳至主要内容
临床试验/NCT05023811
NCT05023811已完成1 期

A Phase I, Open-label Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]RIST4721 Following a Single Oral Dose to Healthy Male Subjects

Aristea Therapeutics, Inc.1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2021年8月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
6
试验地点
1
主要终点
Collection of plasma, urine and fecal samples for structural identification

研究概览

简要总结

A Phase I, Open-label Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]RIST4721 Following a Single Oral Dose to Healthy Male Subjects

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
30 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy males
  • Must provide written informed consent
  • Body mass index (BMI) 18.0 to 30.0 kg/m2 as measured at screening
  • Weight ≥50 kg and ≤100 kg inclusive at screening
  • Must have regular bowel movements (ie average stool production of ≥1 and ≤3 stools per day)

排除标准

  • Subjects who have received any IMP in a clinical research study within the 90 days prior to Day 1
  • Evidence of current SARS-CoV-2 infection
  • Radiation exposure, including that from the present study, excluding background radiation but including diagnostic x-rays and other medical exposures, exceeding 5 mSv in the last 12 months or 10 mSv in the last 5 years. No occupationally exposed worker, as defined in the Ionising Radiation Regulations 2017, shall participate in the study

研究组 & 干预措施

[14C]RIST4721

Experimental

[14C]RIST4721 oral solution

干预措施: [14C]RIST4271 (Drug)

结局指标

主要结局

Collection of plasma, urine and fecal samples for structural identification

时间窗: Day 1 to Day 17

Collection of plasma, urine and fecal samples for quantification analysis

时间窗: Day 1 to Day 17

Determination of routes and rates of elimination of [14C]RIST4721 by Ae

时间窗: Day 1 to Day 17

Determination of routes and rates of elimination of [14C]RIST4721 by CumAe

时间窗: Day 1 to Day 17

Determination of routes and rates of elimination of [14C]RIST4721 by Cum%Ae by interval

时间窗: Day 1 to Day 17

Mass balance recovery of total radioactivity in all excreta: CumAe

时间窗: Day 1 to Day 17

Mass balance recovery of total radioactivity in all excreta: Cum%Ae

时间窗: Day 1 to Day 17

Determination of routes and rates of elimination of [14C]RIST4721 by %Ae

时间窗: Day 1 to Day 17

Collection of plasma, urine and fecal samples for metabolite profiling

时间窗: Day 1 to Day 17

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study of the ADME of [14C]RIST4721 in Healthy Male... | 临床试验